These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25968237)

  • 1. Carbamate nerve agent prophylatics exhibit distinct toxicological effects in the zebrafish embryo model.
    Fischer A; Wolman M; Granato M; Parsons M; McCallion AS; Proescher J; English E
    Neurotoxicol Teratol; 2015; 50():1-10. PubMed ID: 25968237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anticholinesterase drugs on biomarkers and behavior of pumpkinseed, Lepomis gibbosus (Linnaeus, 1758).
    Rodrigues S; Antunes SC; Brandão FP; Castro BB; Gonçalves F; Nunes B
    J Environ Monit; 2012 May; 14(6):1638-44. PubMed ID: 22576010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
    Herkert NM; Thiermann H; Worek F
    Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function.
    Telford G; Wilkinson LJ; Hooi DS; Worrall V; Green AC; Cook DL; Pritchard DI; Griffiths GD
    Int Immunopharmacol; 2004 Nov; 4(12):1455-66. PubMed ID: 15351315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model.
    Griffiths GD; Telford G; Hooi DS; Cook DL; Wilkinson LJ; Green CA; Pritchard DI
    Int Immunopharmacol; 2005 Mar; 5(3):525-40. PubMed ID: 15683849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors.
    Behra M; Etard C; Cousin X; Strähle U
    Toxicol Sci; 2004 Feb; 77(2):325-33. PubMed ID: 14657522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamate protection of AChE against inhibition by agricultural chemicals.
    Wilson BW; Rusli FJ; Yan Tam MK; DePeters E; Henderson JD
    J Biochem Mol Toxicol; 2012 Dec; 26(12):506-9. PubMed ID: 23169765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
    Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
    J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradycardia produced by pyridostigmine and physostigmine.
    Stein RD; Backman SB; Collier B; Polosa C
    Can J Anaesth; 1997 Dec; 44(12):1286-92. PubMed ID: 9429048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine.
    Chaney LA; Rockhold RW; Mozingo JR; Hume AS; Moss JI
    Vet Hum Toxicol; 1997 Aug; 39(4):214-9. PubMed ID: 9251170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
    Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
    J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity.
    Banerjee J; Ghosh P; Mitra S; Ghosh N; Bhattacharya S
    J Toxicol Environ Health; 1991 Jul; 33(3):283-90. PubMed ID: 1906943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute behavioral toxicity of pyridostigmine or soman in primates.
    Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.